![](/img/cover-not-exists.png)
33PCombination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer
Martins, F C, Couturier, D-L, de Santiago, I, Vias, M, Sanders, D, Piskorz, A, Hall, J, Jimenez-Linan, M, Hosking, K, Crawford, R, Brenton, JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz413.038
Date:
November, 2019
File:
PDF, 87 KB
2019